Opus Genetics (IRD) Share-based Compensation Growth (1y) (2011 - 2026)
Opus Genetics (IRD) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-69.95% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
0.18% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Opus Genetics |
355.39 Mn |
295.43 Mn |
- |
60.35% |
| Date | Value |
|---|
| Mar 31, 2026 |
60.35% |
| Dec 31, 2025 |
-179.85% |
| Jun 30, 2025 |
11.17% |
| Mar 31, 2025 |
272.65% |
| Dec 31, 2024 |
344.73% |
| Jun 30, 2024 |
-43.32% |
| Mar 31, 2024 |
-99.90% |
| Dec 31, 2023 |
157.85% |
| Sep 30, 2023 |
478.79% |
| Jun 30, 2023 |
219.55% |
| Mar 31, 2023 |
55,405.62% |
| Dec 31, 2022 |
-356.58% |
| Sep 30, 2022 |
280.77% |
| Jun 30, 2022 |
1,434.48% |
| Mar 31, 2022 |
-9.92% |
| Dec 31, 2021 |
-6.63% |
| Sep 30, 2021 |
-95.78% |
| Jun 30, 2021 |
-90.82% |
| Mar 31, 2021 |
709.84% |
| Dec 31, 2020 |
819.01% |
